{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:18:58Z","timestamp":1792592338478,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To assess the repeatability and reproducibility of quantitative MRCP-derived metrics generated from MRCP\u2009+\u2009software, designed for assessing biliary tree health.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Metric accuracy was assessed using a 3D-printed phantom containing 20 tubes with sinusoidally-varying diameters, simulating strictures and dilatations along ducts. Data from 80 participants (60 healthy volunteers and 20 with liver disease) was analysed in total. Repeatability and reproducibility of the quantitative metrics were assessed on Siemens, GE and Philips scanners at both 1.5T and 3T. All subjects were scanned on a Siemens Prisma 3T scanner which acted as the reference scanner. A subset of these participants also underwent scanning on the remaining scanners. Data from healthy volunteers was used to estimate the natural range of measured values (reference ranges). The reproducibility coefficient (RC) of 7 commonly reported quantitative metrics were compared between healthy controls and published values in primary sclerosing cholangitis (PSC) patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The phantom analysis confirmed measurement accuracy with absolute bias of 0.0-0.1 for strictures and 0.1\u20130.2 for dilatations across all scanners (95% limits of agreement within \u00b1\u20091.0). In vivo, RCs for the quantitative MRCP-derived metrics across the scanners ranged from: 12.4\u201325.4 for total number of ducts; 4.9\u20137.9 for number of dilatations; 3.3\u20136.5 for number of strictures; 4.6\u20139.8\u00a0mm for total length of dilatations; 26.5\u201351.7\u00a0mm for total length of strictures; and 4.4\u20136.8 for number of ducts with a stricture or dilatation. Repeatability on the same scanner was generally better than comparisons across scanners. Six metrics demonstrated sufficient cross-scanner reproducibility to distinguish healthy volunteers from PSC patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The precision of quantitative MRCP-derived metrics were sufficient to differentiate PSC and healthy subjects and should be well suited for multi-centre trials and assessment of biliary tree health.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00261-025-04941-9","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:51:50Z","timestamp":1744851110000},"page":"5211-5222","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Accuracy, repeatability, reproducibility and reference ranges of primary sclerosing cholangitis specific biomarkers from quantitative MRCP"],"prefix":"10.1007","volume":"50","author":[{"given":"Mukesh","family":"Harisinghani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Ralli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Paun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Borghetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kartik","family":"Jhaveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Del Grande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Finnegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Pansini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"key":"4941_CR1","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","volume":"382","author":"GM Hirschfield","year":"2013","unstructured":"Hirschfield GM, Karlsen TH, Lindor KD, Adams DH. Primary sclerosing cholangitis. Lancet. 2013;382:1587\u201399.","journal-title":"Lancet"},{"key":"4941_CR2","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/hep.32771","volume":"77","author":"CL Bowlus","year":"2023","unstructured":"Bowlus CL, Arriv\u00e9 L, Bergquist A, Deneau M, Forman L, Ilyas SI. AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology. 2023;77:659\u2013702.","journal-title":"Hepatology"},{"key":"4941_CR3","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1136\/gutjnl-2018-317993","volume":"68","author":"MH Chapman","year":"2019","unstructured":"Chapman MH, Thorburn D, Hirschfield GM, Webster GGJ, Rushbrook SM, Alexander G. British Society of Gastroenterology and UK- PSC guidelines for the diagnosis and management of primary sclerosing cholangitis. Gut. 2019;68:1356\u201378.","journal-title":"Gut"},{"key":"4941_CR4","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","volume":"77","author":"O Chazouilleres","year":"2022","unstructured":"Chazouilleres O, Beuers U, Bergquist A, Karlsen TH, Levy C, Samyn M. EASL clinical practice guidelines on sclerosing cholangitis. J Hepatol. 2022;77:761\u2013806.","journal-title":"J Hepatol"},{"key":"4941_CR5","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/hep.28128","volume":"63","author":"PJ Trivedi","year":"2016","unstructured":"Trivedi PJ, Corpechot C, Pares A, Hirschfield GM. Risk stratification in autoimmune cholestatic liver diseases: opportunities for clinicians and trialists. Hepatology. 2016;63:644\u201359.","journal-title":"Hepatology"},{"issue":"33","key":"4941_CR6","first-page":"5209","volume":"11","author":"TZ Ong","year":"2005","unstructured":"Ong TZ, Khor JL, Selamat DS, Yeoh KG, Ho KY, Tz O, et al. Complications of endoscopic retrograde cholangiography in the post-MRCP era: A tertiary center experience. World J Gastroenterol [Internet]. 2005;11(33):5209\u201312. Available from: www.wjgnet.com","journal-title":"World J Gastroenterol [Internet]"},{"issue":"12","key":"4941_CR7","doi-asserted-by":"publisher","first-page":"100595","DOI":"10.1016\/j.jhepr.2022.100595","volume":"4","author":"A Grigoriadis","year":"2022","unstructured":"Grigoriadis A, Ringe KI, Bengtsson J, Baubeta E, Forsman C, Korsavidou-Hult N, Rorsman F, Nilsson E, Kartalis N, Bergquist A. Development of a prognostic MRCP-score (DiStrict) for individuals with large-duct primary sclerosing cholangitis. JHEP Reports. 2022;4(12):100595.","journal-title":"JHEP Reports"},{"key":"4941_CR8","doi-asserted-by":"crossref","unstructured":"Grigoriadis A, Ringe KI, Andersson M, Kartalis N, Bergquist A. Assessment of prognostic value and interreader agreement of ANALI scores in patients with primary sclerosing cholangitis. Eur J Radiol. 2021;142.","DOI":"10.1016\/j.ejrad.2021.109884"},{"issue":"3","key":"4941_CR9","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/jmri.27113","volume":"52","author":"MH Goldfinger","year":"2020","unstructured":"Goldfinger MH, Ridgway GR, Ferreira C, Langford CR, Cheng L, Kazimianec A, et al. Quantitative MRCP Imaging: Accuracy, Repeatability, Reproducibility, and Cohort-Derived Normative Ranges. Journal of Magnetic Resonance Imaging. 2020;52(3):807\u201320.","journal-title":"Journal of Magnetic Resonance Imaging"},{"issue":"1","key":"4941_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00330-021-08142-y","volume":"32","author":"MF Ismail","year":"2022","unstructured":"Ismail MF, Hirschfield GM, Hansen B, Tafur M, Elbanna KY, Goldfinger MH, et al. Evaluation of quantitative MRCP (MRCP+) for risk stratification of primary sclerosing cholangitis: comparison with morphological MRCP, MR elastography, and biochemical risk scores. European Radiology. 2022;32(1):67\u201377.","journal-title":"European Radiology"},{"key":"4941_CR11","doi-asserted-by":"crossref","unstructured":"Arndtz K, Hodson J, Eddowes P. Quantitative biliary tree imaging by MRI: Evaluating new technology across patient cohorts with autoimmune liver disease. J Hepatol. 2019;","DOI":"10.1016\/S0618-8278(19)30818-7"},{"key":"4941_CR12","doi-asserted-by":"crossref","unstructured":"Kristina I. Ringe, Annika Bergquist, Henrike Lenzen, Michael P. Manns, Frank Wacker, Aristeidis Grigoriadis. Clinical features and MRI progression of small duct primary sclerosing cholangitis (PSC). Eur J Radiol. 2020;129.","DOI":"10.1016\/j.ejrad.2020.109101"},{"key":"4941_CR13","doi-asserted-by":"crossref","unstructured":"Selvaraj EA, Ba-Ssalamah A, Poetter-Lang S, Ridgway GR, Brady JM, Collier J, et al. A Quantitative Magnetic Resonance Cholangiopancreatography Metric of Intrahepatic Biliary Dilatation Severity Detects High-Risk Primary Sclerosing Cholangitis. Hepatol Commun [Internet]. 2022;6(4):795. Available from: http:\/\/journals.lww.com\/hepcomm","DOI":"10.1002\/hep4.1860"},{"key":"4941_CR14","doi-asserted-by":"crossref","unstructured":"Janowski K, Shumbayawonda E, Cheng L, Langford C, Dennis A, Kelly M, et al. Quantitative multiparametric MRI as a non-invasive stratification tool in children and adolescents with autoimmune liver disease. Sci Rep. 2021;11(1).","DOI":"10.1038\/s41598-021-94754-9"},{"key":"4941_CR15","doi-asserted-by":"publisher","unstructured":"Trivedi PJ, Arndtz K, Abbas N, Telford A, Young L, Banerjee R, et al. Quantitative MRCP and metrics of bile duct disease over time in patients with primary sclerosing cholangitis: A prospective study. Aliment Pharmacol Ther [Internet]. 2024; Available from: https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1111\/apt.17944","DOI":"10.1111\/apt.17944"},{"issue":"1","key":"4941_CR16","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s00261-019-02184-z","volume":"45","author":"L Gilligan","year":"2020","unstructured":"Gilligan L, Trout A, Lam S, Singh R, Tkach J, Serai SD, et al. Differentiating pediatric autoimmune liver diseases by quantitative magnetic resonance cholangiopancreatography. Abdom Radiol. 2020;45(1):168\u201376.","journal-title":"Abdom Radiol"},{"issue":"3","key":"4941_CR17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.dld.2022.10.015","volume":"55","author":"L Cristoferi","year":"2023","unstructured":"Cristoferi L, Porta M, Bernasconi DP, Leonardi F, Gerussi A, Mulinacci G, et al. A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis. Digestive and Liver Disease. 2023;55(3):373\u201380.","journal-title":"Digestive and Liver Disease"},{"key":"4941_CR18","doi-asserted-by":"crossref","unstructured":"Vuppalanchi R, Are V, Telford A, Young L, Mouchti S, Ferreira C, et al. A composite score using quantitative magnetic resonance cholangiopancreatography predicts clinical outcomes in primary sclerosing cholangitis. JHEP Reports. 2023;5(10).","DOI":"10.1016\/j.jhepr.2023.100834"},{"key":"4941_CR19","doi-asserted-by":"crossref","unstructured":"Cazzagon N, El Mouhadi S, Vanderbecq Q, Ferreira C, Finnegan S, Lemoinne S, et al. Quantitative magnetic resonance cholangiopancreatography metrics are associated with disease severity and outcomes in people with primary sclerosing cholangitis. JHEP Reports. 2022;4(11).","DOI":"10.1016\/j.jhepr.2022.100577"},{"key":"4941_CR20","doi-asserted-by":"crossref","unstructured":"Frangi AF, Niessen WJ, Vincken KL, Viergever MA. Multiscale vessel enhancement filtering. Medical Image Computing and Computer-Assisted Intervention 1998 Oct 11","DOI":"10.1007\/BFb0056195"},{"key":"4941_CR21","unstructured":"Ralli GP, Ridgway GR, Brady SM. Segmentation of the biliary tree from MRCP images via the monogenic signal. Medical Image Understanding and Analysis: 24th Annual Conference, MIUA 2020, Oxford, UK, July 15\u201317, 2020, Proceedings 24 2020"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-04941-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-025-04941-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-04941-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:03:31Z","timestamp":1761847411000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-025-04941-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":21,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["4941"],"URL":"https:\/\/doi.org\/10.1007\/s00261-025-04941-9","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]},"assertion":[{"value":"8 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"TD, GR, CF, BP, AB, AD, MP, and SF are employees of Perspectum Ltd, which develops the MRCP+ software evaluated in this study. MH, KJ, and FDG have no competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}